Hepatolithiasis and intrahepatic cholangiocarcinoma: Carcinogenesis based on molecular mechanisms

Journal of Hepato-Biliary-Pancreatic Surgery

Volumn 12, Issue 6, 2005, Pages 463-466

  Kuroki, Tamotsu ^a   Tajima, Yoshitsugu ^a   Kanematsu, Takashi ^a  

^a NAGASAKI UNIVERSITY   (Japan)

Author keywords

Hepatolithiasis; Intrahepatic cholangiocarcinoma; Molecular mechanism

Indexed keywords

CYCLOOXYGENASE 2; PROSTAGLANDIN E2; PROTEIN P16; TRANSCRIPTION FACTOR CDX2;

ASIA; BILE DUCT CARCINOMA; BILE DUCT STONE; CANCER RISK; CARCINOGENESIS; CELL CYCLE; CELL PROLIFERATION; GENE MUTATION; GENETIC ASSOCIATION; HELICOBACTER; HUMAN; INCIDENCE; LIVER RESECTION; OUTCOMES RESEARCH; REGULATORY MECHANISM; REVIEW; RISK ASSESSMENT; WESTERN HEMISPHERE;

BILE DUCTS, INTRAHEPATIC; CHOLANGIOCARCINOMA; CYCLOOXYGENASE 2; DINOPROSTONE; GALLSTONES; GENES, P16; HELICOBACTER INFECTIONS; HOMEODOMAIN PROTEINS; HUMANS; LIVER NEOPLASMS; MEMBRANE PROTEINS; PROTO-ONCOGENE PROTEINS C-MET;

EID: 31144453259     PISSN: 09441166     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00534-005-1004-1     Document Type: Review

References (50)

1. F Nakayama. 1985 Hepatolithiasis and cholangiohepatitis. In: S Cohen, RD Soloway, editors. Gallstones. New York: Churchill Livingstone; p. 237-6.
2. F Nakayama. 1994 Intrahepatic stones. In: LH Blumgart, editor. Surgery of the liver and Piliary tract. New York: Churchill Livingstone: p. 765-74.
3. T Ohta, T Nagakawa, N Ueda, T Nakamura, T Akiyama, K Ueno, et al. 1991 Mucosal dysplasia of the liver and the intraductal variant of peripheral cholangiocarcinoma in hepatolithiasis. Cancer 68:2217-23. 1655206 1:STN:280:By2D3crhslI%3D
4. KM Chu, CM Lo, CL Liu, ST Fan. 1996 Malignancy associated with hepatolithiasis. Hepatogastroenterology 43:614-19.
5. CH Su, YM Shyr, WY Lui, FK P'Eng. 1997 Hepatolithiasis associated with cholangiocarcinoma. Br J Surg 84:969-73. 9240138 1:STN:280:ByiA1cvkslQ%3D
6. T Shimonishi, M Sasaki, Y Nakanuma (2000) Precancerous lesions of intrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Surg 7:542-50. 11180885 10.1007/s005340070002 1:STN:280:DC%2BD3M3gtFeluw%3D%3D
7. Y Nakanuma, K Harada, A Ishikawa, Y Zen, M Sasaki. 2003 Anatomic and molecular pathology of intrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Surg 10:265-81. 14598145 10.1007/s00534-002-0729-3
8. Liver Cancer Study Group of Japan 1990 Primary liver cancer in Japan. Clinicopathologic features and results of surgical treatment. Ann Surg 211:277-87.
9. MR Bhuiya, Y Nimura, J Kamiya, S Kondo, S Fukata, N Hayakawa, et al. 1992 Clinicopathologic studies on perineural invasion of bile duct carcinoma. Ann Surg 215:344-9. 1558415 1:STN:280:By2B3MvpvVM%3D
10. Y Shaib, HB El-Serag 2004 The epidemiology of cholangiocarcinoma. Semin Liver Dis 24:115-25. 15192785 10.1055/s-2004-828889
11. SA Ahrendt, A Rashid, JT Chow, CF Eisenberger, HA Pitt, D Sidransky. 2000 p53 overexpression and K-rans gene mutations in primary sclerosing cholangitis-associated biliary tract cancer. J Hepatobiliary Pancreat Surg 7:426-31. 11180865 10.1007/s005340070039 1:STN:280:DC%2BD3M3gsFChsg%3D%3D
12. S Yoshida, T Todoroki, Y Ichikawa, S Hanai, H Suzuki, M Hori, et al. 1995 Mutations of p16Ink4/CDKN2 and p15Ink4B/MTS2 genes in biliary tract cancers. Cancer Res 55:2756-60. 7796400 1:CAS:528:DyaK2MXmsFyksrk%3D
13. T Terada, Y Nakanuma. 1992 Cell kinetic analyses and expression of carcinoembryonic antigen, carbohydrate antigen 19-9 and DU-PAN-2 in hyperplastic, pre-neoplastic and neoplastic lesions of intrahepatic bile ducts in livers with hepatoliths. Virchows Arch A Pathol Anat Histopathol 420:327-35. 1348889 10.1007/BF01600212 1:STN:280:By2B3s%2FhvFQ%3D
14. CT Sherr. 1996 Cancer cell cycles. Science 276:1672-7.
15. WH Liggett Jr, D Sidransky. 1998 Role of the p16 tumor suppressor gene in cancer. J Clin Oncol 16:1197-206. 9508208 1:CAS:528:DyaK1cXitVKitb8%3D
16. ink4a inactivation is an early and frequent event of intraductal papillary neoplasm of the liver arising in hepatolithiasis. Hum Pathol 35:1505-14. 15619210 10.1016/ j.humpath.2004.08.014 1:CAS:528:DC%2BD2cXhtVyku77E
17. AK Virmani, C Muller, A Rathi, S Zoechbauer-Mueller, M Mathis, AF Gazdar. 2001 Aberrant methylation during cervical carcinogenesis. Clin Cancer Res 7:584-9 11297252 1:CAS:528:DC%2BD3MXjtVOgurk%3D
18. GH Kang, YH Shim, HY Jung, WH Kim, JY Ro, Rhyu MG. CpG 2001 island methylation in premalignant stages of gastric carcinoma. Cancer Res 61:2847-51. 11306456 1:CAS:528:DC%2BD3MXivFGru74%3D
19. INK4a as detected in pancreatic secretions. Br J Cancer 88:217-22. 12610506 10.1038/ sj.bjc.6600734 1:CAS:528:DC%2BD3sXhsV2rtbw%3D
20. A Tannapfel, F Sommerer, M Benicke, L Weinans, A Katalinic, F Geissler, et al. 2002 Genetic and epigenetic alterations of the INK4a-ARF pathway in cholangiocarcinoma. J Pathol 197:624-31. 12210082 10.1002/path.1139 1:CAS:528:DC%2BD38Xntleku78%3D
21. T Kuroki, F Trapasso, S Yendamuri, A Matsuyama, H Alder, M Mori, et al. 2003 Promoter hypermethylation of RASSF1A in esophageal squamous cell carcinoma. Clin Cancer Res 9:1441-5. 12684417 1:CAS:528:DC%2BD3sXislertLk%3D
22. T Kuroki, F Trapasso, S Yendamuri, A Matsuyama, H Alder, NN Williams, et al. 2003 Allelic loss on chromosome 3p21.3 and promoter hypermethylation of Semaphorin 3B in non-small cell lung cancer. Cancer Res 63:3352-5. 12810670 1:CAS:528:DC%2BD3sXks1ehsrk%3D
23. T Kuroki, F Trapasso, S Yendamuri, A Matsuyama, H Alder, M Mori, et al. 2003 Allele loss and promoter hypermethylation of VHL, RAR-β, RASSF1A, and FHIT tumor supporessor genes on chromosome 3p in esophageal squamous cell carcinoma. Cancer Res 63:3724-8. 12839965 1:CAS:528:DC%2BD3sXltVGqsr8%3D
24. S Chariyalertsak, V Sirikulchayanonta, D Mayer, A Kopp-Schneider, G Furstenberger, F Marks, et al. 2001 Aberrant cyclooxygenase isozyme expression in human intrahepatic cholangiocarcinoma. Cut 48:80-6. 1:CAS:528:DC%2BD3MXntFKmsQ%3D%3D
25. N Hayashi, H Yamamoto, N Hiraoka, K Dono, Y Ito, J Okami, et al. 2001 Differential expression of cyclooxygenase-2 (COX-2) in human bile duct epithelial cells and bile duct neoplasm. Hepatology 34:638-50. 11584358 10.1053/jhep.2001.28198 1:CAS:528:DC%2BD3MXns1Kju7k%3D
26. Y Sun, XM Tang, E Half, MT Kuo, FA Sinicrope. 2002 Cyclooxygenase-2 overexpression reduces apoptotic susceptibility by inhibiting the cytochrome c-dependent apoptotic pathway in human colon cancer cells. Cancer Res 62:6323-8. 12414664 1:CAS:528:DC%2BD38XosF2msbg%3D
27. MK Jones, H Wang, BM Peskar, E Levin, RM Itani, IJ Sarfeh, et al. 1999 Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing. Nat Med 5:1418-23. 10581086 1:CAS:528:DyaK1MXnvFGju7g%3D
28. M Tsujii, S Kawano, S Tsuji, H Sawaoka, M Hori, RN DuBois. 1988 Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 93:705-16.
29. A Tsuchida, Y Nagakawa, K Kasuya, T Itoi, M Endo, T Ozawa, et al. 2003 Immunohistochemical analysis of cyclooxygenase-2 and vascular endothelial growth factor in pancreaticobiliary maljunction. Oncol Rep 10:339-43. 12579269 1:CAS:528:DC%2BD3sXhvFGks7k%3D
30. K Endo, BI Yoon, C Pairojkul, AJ Demetris, AE Sirica. 2002 ERBB-2 overexpression and cyclooxygenase-2 up-regulation in human cholangiocarcinoma and risk conditions. Hepatology 36:439-50. 12143054 10.1053/jhep.2002.34435 1:CAS:528:DC%2BD38XmsVansLY%3D
31. WR Jarnagin, Y Fong, RP DeMatteo, M Gonen, EC Burke, J Bodniewicz, et al. 2001 Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg 234:507-19. 11573044 10.1097/ 00000658-200110000-00010 1:STN:280:DC%2BD3MrisFCqtA%3D%3D
32. GA Kune, S Kune, LF Watson. 1988 Colorectal cancer risk, chronic illnesses, operations, and medications: Case control results from the Melbourne Colorectal Cancer Study. Cancer Res 48:4399-404. 3390835 1:STN:280:BieB2s%2FjvFw%3D
33. E Giovannucci, KM Egan, DJ Hunter, MJ Stampfer, GA Colditz, WC Willett, et al. 1995 Aspirin and the risk of colorectal cancer in women. N Engl J Med 333:609-14. 7637720 10.1056/NEJM199509073331001 1:CAS:528:DyaK2MXoslSgtb4%3D
34. N Matsuhashi, A Nakajima, Y Fukushima, Y Yazaki, T Oka. 1997 Effects of sulindac on sporadic colorectal adenomatous polyps. Gut 40:344-9. 9135523 1:CAS:528:DyaK2sXivVWqtbo%3D
35. N Tsuneoka, Y Tajima, A Kitazato, K Fukuda, T Kitajima, T Kuroki, et al. 2005 Chemopreventative effect of a cyclooxygenase-2-specific inhibitor (etodolac) on chemically induced biliary carcinogenesis in hamsters. Carcinogenesis 26:465-9. 15498790 1:CAS:528:DC%2BD2MXmsVyluw%3D%3D
36. J Shoda, T Ueda, T Kawamoto, T Todoroki, T Asano, Y Sugimoto, et al. 2003 Prostaglandin E receptors in bile ducts of hepatolithiasis patients and the pathobiological significance for cholangitis. Clin Gastroenterol Hepatol 1:285-96. 15017670 10.1016/S1542-3565(03)00133-2 1:CAS:528:DC%2BD3sXmvVCns7g%3D
37. T Ueki, J Fujimoto, T Suzuki, H Yamamoto, E Okamoto. 1997 Expression of hepatocyte growth factor and its receptor c-met proto-oncogene in hepatocellular carcinoma. Hepatology 25:862-6. 9096589 1:STN:280:ByiB2M%2FptVI%3D
38. SI Aishima, KI Taguchi, K Sugimachi, M Shimada, K Sugimachi. 2002 Tsuneyoshi M. c-erbB-2 and c-Met expression relates to cholangiocarcinogenesis and progression of intrahepatic cholangiocarcinoma. Histopathology 40:269-78. 11895493 10.1046/ j.1365-2559.2002.00353.x
39. H Varnholt, Y Asayama, S Aishima, K Taguchi, K Sugimachi, M Tsuneyoshi. 2002 C-met and hepatocyte growth factor expression in combined hepatocellular and cholangiocarcinoma. Oncol Rep 9:35-41. 11748452 1:CAS:528:DC%2BD38XmtVSjtA%3D%3D
40. T Terada, Y Nakanuma, AE Sirica. 1998 Immunohistochemical demonstration of MET overexpression in human intrahepatic cholangiocarcinoma and in hepatolithiasis. Hum Pathol 29:175-80. 9490278 10.1016/ S0046-8177(98)90229-5 1:CAS:528:DyaK1cXhs1ait7o%3D
41. T Kokuryo, T Yamamoto, K Oda, J Kamiya, Y Nimura, T Senga, et al. 2003 Profiling of gene expression associated with hepatolithiasis by complementary DNA expression array. Int J Oncol 22:175-9. 12469201 1:CAS:528:DC%2BD3sXhsVSmsA%3D%3D
42. T Brabletz, S Spaderna, J Kolb, F Hlubek, G Faller, CJ Bruns, et al. 2004 Down-regulation of the homeodomain factor Cdx2 in colorectal cancer by collagen type I: An active role for the tumor environment in malignant tumor progression. Cancer Res 64:6973-7. 15466189 10.1158/ 0008-5472.CAN-04-1132 1:CAS:528:DC%2BD2cXotFalsL4%3D
43. Y Yuasa, H Nagasaki, Y Akiyama, H Sakai, T Nakajima, Y Ohkura, et al. 2005 Relationship between CDX2 gene methylation and dietary factors in gastric cancer patients. Carcinogenesis 26:193-200. 15498792 1:CAS:528:DC%2BD2MXisVSlsA%3D%3D
44. H Kawai, K Tomii, S Toyooka, M Yano, M Murakami, K Tsukuda, et al. 2005 Promoter methylation downregulates CDX2 expression in colorectal carcinomas. Oncol Rep 13:547-51. 15706431 1:CAS:528:DC%2BD2MXisVSms7c%3D
45. A Ishikawa, M Sasaki, S Ohira, T Ohta, K Oda, Y Nimura, et al. 2004 Aberrant expression of CDX2 is closely related to the intestinal metaplasia and MUC2 expression in intraductal papillary neoplasm of the liver in hepatolithiasis. Lab Invest 84:629-38. 15048136 10.1038/ labinvest.3700087 1:CAS:528:DC%2BD2cXmtF2isbc%3D
46. S Yonezawa, K Sueyoshi, M Nomoto, H Kitamura, K Nagata, Y Arimura, et al. 1997 MUC2 gene expression is found in noninvasive tumors but not in invasive tumors of the pancreas and liver: Its close relationship with prognosis of the patients. Hum Pathol 28:34-52. 10.1016/ S0046-8177(97)90134-9
47. A Nomura, GN Stemmermann, PH Chyou, I Kato, GI Perez-Perez, MJ Blaser. 1991 Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med 325:1132-6. 1891021 1:STN:280:By6A28jitlQ%3D
48. EJ Kuipers, AM Uyterlinde, AS Pena, R Roosendaal, G Pals, GF Nelis, et al. 1995 Long-term sequelae of Helicobacter pylori gastritis. Lancet 345:1525-8. 7791437 10.1016/S0140-6736(95)91084-0 1:STN:280:ByqA3M7lsVE%3D
49. JG Fox, FE Dewhirst, Z Shen, Y Feng, NS Taylor, BJ Paster, et al. 1998 Hepatic Helicobacter species identified in bile and gallbladder tissue from Chileans with chronic cholecystitis. Gastroenterology 114:755-63. 9516396 10.1016/S0016-5085(98)70589-X 1:STN:280:DyaK1c7osVyjsQ%3D%3D
50. T Kuroki, K Fukuda, K Yamanouchi, T Kitajima, S Matsuzaki, Y Tajima, et al. 2002 Helicobacter pylori accelerates the biliary epithelial cell proliferation activity in hepatolithiasis. Hepatogastroenterology 49:648-51. 12063961